These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 4389816)

  • 1. The effects of reserpine, alpha-methyltyrosine, and L-3,4-dihydroxyphenylalanine on brain tyrosine transaminase.
    Gibb JW; Webb JG
    Proc Natl Acad Sci U S A; 1969 Jun; 63(2):364-9. PubMed ID: 4389816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
    Corrodi H; Fuxe K
    Life Sci; 1967 Jul; 6(13):1345-50. PubMed ID: 6035763
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the interaction between catecholamines and tyrosine aminotransferase in brain.
    Zigmond MJ; Wilson SP
    Biochem Pharmacol; 1973 Sep; 22(17):2151-63. PubMed ID: 4147420
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.
    Ahlenius S
    Neuropharmacology; 1974 Aug; 13(8):729-39. PubMed ID: 4444759
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of alpha-methyltyrosine on operant behavior and brain catecholamine levels.
    Schoenfeld RI; Seiden LS
    J Pharmacol Exp Ther; 1969 Jun; 167(2):319-27. PubMed ID: 5787869
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of L-DOPA on brain catecholamines and motility in rats.
    Maj J; Grabowska M; Mogilnicka E
    Psychopharmacologia; 1971; 22(2):162-71. PubMed ID: 5124189
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the role of catecholamines as regulators of tyrosine aminotransferase.
    Govier WC; Lovenberg W; Sjoerdsma A
    Biochem Pharmacol; 1969 Oct; 18(10):2661-6. PubMed ID: 4397870
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the effectiveness of deserpidine, reserpine, and alpha-methyltyrosine on brain biogenic amines.
    Fulton SC; Healy MD
    Fed Proc; 1976 Dec; 35(14):2558-62. PubMed ID: 11134
    [No Abstract]   [Full Text] [Related]  

  • 9. Importance of catecholamines for the interaction between reserpine and desipramine on body temperature in rats.
    Jori A; Bernardi D
    Pharmacology; 1970; 4(4):235-41. PubMed ID: 5489997
    [No Abstract]   [Full Text] [Related]  

  • 10. Restoration of locomotor activity in mice by low L-DOPA doses after suppression by alpha-methyltyrosine but not by reserpine.
    Ahlenius S; Andén NE; Engel J
    Brain Res; 1973 Nov; 62(1):189-99. PubMed ID: 4358099
    [No Abstract]   [Full Text] [Related]  

  • 11. Refillment of the catecholamine stores with 3,4-dihydroxyphenylalanine after depletion induced by inhibition of tyrosine-hydroxylase.
    Corrodi H; Fuxe K; Hökfelt T
    Life Sci; 1966 Apr; 5(7):605-11. PubMed ID: 5960198
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of the protective effect of reserpine on aggregated mice treated with (+)-amphetamine.
    Menon MK; Dandiya PC
    J Pharm Pharmacol; 1967 Sep; 19(9):596-602. PubMed ID: 4383144
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine and 5,7-dihydroxytryptamine on the hippocampal kindling effect in rats.
    Araki H; Aihara H; Watanabe S; Yamamoto T; Ueki S
    Jpn J Pharmacol; 1983 Dec; 33(6):1177-82. PubMed ID: 6230476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the relationship between drug-induced changes in brain amines and body temperature.
    Ingenito AJ; Bonnycastle DD
    Can J Physiol Pharmacol; 1967 Jul; 45(4):723-32. PubMed ID: 5298528
    [No Abstract]   [Full Text] [Related]  

  • 15. Reserpine and the monoaminergic regulation of adrenal dopamine beta-hydroxylase activity.
    Lima L; Sourkes TL
    Neuroscience; 1986; 17(1):235-45. PubMed ID: 2938024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of apomorphine, alpha-methylparatyrosine, haloperidol and reserpine on DOPA production in clonal cell lines (PC-12 and N1E-115).
    Bräutigam M; Laschinski G; Kittner B; Herken H
    Biochem Pharmacol; 1985 Apr; 34(7):941-7. PubMed ID: 3921032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of pimozide, haloperidol, alpha-methyl-p-tyrosine and reserpine on the development of morphine dependence in rats.
    Kruszewska A; Langwiński R
    Drug Alcohol Depend; 1983 Jun; 11(3-4):383-8. PubMed ID: 6311501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postnatal elevation of brain tyrosine hydroxylase activity, without concurrent increases in steady-state catecholamine levels, resulting from dl-alpha-methylparatyrosine administration during embryonic development.
    Lydiard RB; Fossom LH; Sparber SB
    J Pharmacol Exp Ther; 1975 Jul; 194(1):27-36. PubMed ID: 239220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamines in fetal and newborn rat brain.
    Coyle JT; Henry D
    J Neurochem; 1973 Jul; 21(1):61-7. PubMed ID: 4146461
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
    Ahlenius S
    Brain Res; 1974 Mar; 69(1):57-65. PubMed ID: 4150408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.